Follow
Catherine Labbé
Catherine Labbé
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine
P Goyette, C Labbé, TT Trinh, RJ Xavier, JD Rioux
Annals of medicine 39 (3), 177-199, 2007
1602007
GWA studies: rewriting the story of IBD
ML Budarf, C Labbé, G David, JD Rioux
Trends in Genetics 25 (3), 137-146, 2009
1232009
Epigenetic regulation in Parkinson’s disease
C Labbé, O Lorenzo-Betancor, OA Ross
Acta neuropathologica 132, 515-530, 2016
1022016
Standardization of dynamic contrast-enhanced ultrasound for the evaluation of antiangiogenic therapies: the French multicenter Support for Innovative and Expensive Techniques Study
N Lassau, L Chapotot, B Benatsou, V Vilgrain, M Kind, J Lacroix, M Cuinet, ...
Investigative radiology 47 (12), 711-716, 2012
882012
Cerebellar ataxia in progressive supranuclear palsy: an autopsy study of PSP‐C
S Koga, KA Josephs, K Ogaki, C Labbé, RJ Uitti, N Graff‐Radford, ...
Movement Disorders 31 (5), 653-662, 2016
742016
Mitochondrial targeting sequence variants of the CHCHD2 gene are a risk for Lewy body disorders
K Ogaki, S Koga, MG Heckman, FC Fiesel, M Ando, C Labbé, ...
Neurology 85 (23), 2016-2025, 2015
642015
Analysis of COQ2gene in multiple system atrophy
K Ogaki, S Fujioka, MG Heckman, S Rayaprolu, AI Soto-Ortolaza, ...
Molecular neurodegeneration 9, 1-9, 2014
522014
Association of MAPT subhaplotypes with risk of progressive supranuclear palsy and severity of tau pathology
MG Heckman, RR Brennan, C Labbé, AI Soto, S Koga, MA DeTure, ...
JAMA neurology 76 (6), 710-717, 2019
482019
Role for the microtubule-associated protein tau variant p. A152T in risk of α-synucleinopathies
C Labbé, K Ogaki, O Lorenzo-Betancor, AI Soto-Ortolaza, RL Walton, ...
Neurology 85 (19), 1680-1686, 2015
45*2015
MAPT haplotype H1G is associated with increased risk of dementia with Lewy bodies
C Labbé, MG Heckman, O Lorenzo-Betancor, AI Soto-Ortolaza, ...
Alzheimer's & Dementia 12 (12), 1297-1304, 2016
432016
GWAS risk factors in Parkinson’s disease: LRRK2 coding variation and genetic interaction with PARK16
AI Soto-Ortolaza, MG Heckman, C Labbé, DJ Serie, A Puschmann, ...
American journal of neurodegenerative disease 2 (4), 287, 2013
422013
Investigating the role of FUS exonic variants in essential tremor
C Labbé, AI Soto-Ortolaza, S Rayaprolu, AM Harriott, AJ Strongosky, ...
Parkinsonism & related disorders 19 (8), 755-757, 2013
412013
Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorder
J Li, JA Ruskey, I Arnulf, Y Dauvilliers, MTM Hu, B Högl, CS Leblond, ...
Movement Disorders 33 (6), 1016-1020, 2018
362018
LRRK2 variation and dementia with Lewy bodies
MG Heckman, AI Soto-Ortolaza, MYS Contreras, ME Murray, O Pedraza, ...
Parkinsonism & related disorders 31, 98-103, 2016
362016
MAST3: a novel IBD risk factor that modulates TLR4 signaling
C Labbé, P Goyette, C Lefebvre, C Stevens, T Green, MK Tello-Ruiz, ...
Genes & Immunity 9 (7), 602-612, 2008
362008
PCNT point mutations and familial intracranial aneurysms
O Lorenzo-Betancor, PR Blackburn, E Edwards, R Vázquez-do-Campo, ...
Neurology 91 (23), e2170-e2181, 2018
322018
MAPT haplotype diversity in multiple system atrophy
C Labbé, MG Heckman, O Lorenzo-Betancor, ME Murray, K Ogaki, ...
Parkinsonism & related disorders 30, 40-45, 2016
312016
Genome-wide Expression Profiling Implicates a MAST3-Regulated Gene Set in Colonic Mucosal Inflammation of Ulcerative Colitis Patients
C Labbé, G Boucher, S Foisy, A Alikashani, H Nkwimi, G David, ...
Inflammatory bowel diseases 18 (6), 1072-1080, 2012
312012
Genetic variation of the retromer subunits VPS26A/B-VPS29 in Parkinson's disease
B Shannon, A Soto-Ortolaza, S Rayaprolu, HD Cannon, C Labbé, ...
Neurobiology of aging 35 (8), 1958. e1-1958. e2, 2014
282014
Association studies of sporadic Parkinson’s disease in the genomic era
C Labbé, O A Ross
Current genomics 15 (1), 2-10, 2014
282014
The system can't perform the operation now. Try again later.
Articles 1–20